20 (AIDX) Gross Margin (2025 - 2026)
20 (AIDX) posted Gross Margin of 17.8% for Q1 2026, down 40.56% on a QoQ basis from 29.94% in Q1 2025, and down 1214.0% year-over-year from 1.6% in Q1 2025.
20 (AIDX) Gross Margin (2025 - 2026) Analysis & Trends
20's Gross Margin history runs 2 years deep, the most recent figure standing at 17.8% for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 62.95% |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn | 38.53% |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 45.22% |
| 10 | 20 | 3.47 Mn | -751,140.04 | 62,884.00 | 17.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.80% |
| Mar 31, 2025 | 29.94% |